Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNB2 | O95067 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.46 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.45 |
| ▸ | HTR2B | P41595 | 2/20 | 0.45 |
| ▸ | PNMT | P11086 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396030 | 1.00 | CCNB2 (0.46) | CCNB2CDK1CCNB1CCNB3ATM | |
| SCHEMBL5016277 | 0.85 | HTR2A (0.49) | ATMTDP1HTR2AHTR2CHTR2B | |
| SCHEMBL13365442 | 0.79 | ADCY6 (0.44) | PNMTTBXA2R | |
| SCHEMBL16210119 | 0.78 | PNMT (0.57) | HTR2AHTR2CHTR2BPNMTADRA2A | |
| SCHEMBL28340616 | 0.76 | DYRK1A (0.46) | HTR2CHTR2BPNMTADRB2ADRB1 | |
| SCHEMBL18860287 | 0.75 | PNMT (0.48) | HTR2AHTR2CHTR2BPNMTALDH1A1 | |
| SCHEMBL11162952 | 0.73 | HTR2C (0.58) | ATMHTR2AHTR2CHTR2BALDH1A1 | |
| SCHEMBL6223597 | 0.73 | HTR2A (0.50) | ATMTDP1HTR2AHTR2CHTR2B | |
| SCHEMBL11820769 | 0.73 | PNMT (0.49) | HTR2AHTR2CHTR2BPNMTADRB2 | |
| SCHEMBL3882991 | 0.72 | PNMT (0.48) | HTR2AHTR2CHTR2BPNMTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023121486-A1 | COMPOSITIONS AND COMPOUNDS FOR TREATING COVID-19 | INTERNATIONAL PATENT HOLDINGS LLC (KN) | 2023-06-29 | — | — | WO | claimed |
| US-8067401-B2 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LLC (KN) | 2011-11-29 | — | — | US | claimed |
| US-20090069277-A1 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LTD. | 2009-03-12 | — | — | US | claimed |
| US-20260053878-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | NEURAL THERAPEUTICS INC (CA) | 2026-02-26 | — | — | US | disclosed |
| US-12551519-B2 | Extraction system and method for organic metabolites | VCENNA TECH & LABS INC (CA) | 2026-02-17 | — | — | US | disclosed |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | JOURNEY COLAB CORP. | 2025-05-22 | — | — | US | disclosed |
| WO-2024246905-A1 | ENZYMES, POLYNUCLEOTIDES ENCODING SAME, AND METHODS OF USING SAME FOR PRODUCING MESCALINE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-12-05 | — | — | WO | disclosed |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | JOURNEY COLAB CORP. | 2024-07-25 | — | — | US | disclosed |
| US-20240123005-A1 | EXTRACTION SYSTEM AND METHOD FOR ORGANIC METABOLITES | Etminan, Seyed Reza (CA) | 2024-04-18 | — | — | US | disclosed |
| WO-2024040358-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | NEURAL THERAPEUTICS INC. (CA) | 2024-02-29 | — | — | WO | disclosed |
| CN-115785753-B | Bamboo charcoal negative ion coating and preparation method and application thereof | 亚士漆(上海)有限公司 | 2024-01-19 | — | — | CN | disclosed |
| US-8067401-B2 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LLC (KN) | 2011-11-29 | — | — | US | disclosed |
| US-20090069277-A1 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LTD. | 2009-03-12 | — | — | US | disclosed |
| US-20090069277-A1 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LTD. | 2009-03-12 | — | — | US | disclosed |
| US-20090069277-A1 | Compounds and compositions for treating infection | INTERNATIONAL PATENT HOLDINGS LTD. | 2009-03-12 | — | — | US | disclosed |
| EP-0617022-B1 | 6,7, dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound | BANYU PHARMA CO LTD (JP) | 1998-02-11 | — | — | EP | disclosed |
| US-5498717-A | CHEMICAL INTERMEDIATES FOR PRODUCING ANTITUMOR POTENTIATORS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1996-03-12 | — | — | US | disclosed |
| US-5446164-A | Regioselective cyclization of phenethylamide derivative in presence of phosphoric acid halide, reducing formed compound | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0617022-A1 | 6,7, dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
| EP-0443533-A2 | Positive photoresist composition | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053878-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | CARM1, CLK4, NPM1 | CCNB2 212/4885CDK1 1369/4885CCNB1 406/4885 |
| US-20090069277-A1 | Compounds and compositions for treating infection | RPN2, LSS, CLIC4 | CCNB2 3527/4885CDK1 4223/4885CCNB1 4357/4885 |
| US-20240245632-A1 | METHODS OF TREATING SUBSTANCE USE DISORDERS USING MESCALINE | SLC6A12, SLC6A3, TPMT | CCNB2 2642/4885CDK1 3936/4885CCNB1 2819/4885 |
| US-20250162980-A1 | METHODS FOR PREPARING MESCALINE | IL4I1, ME3, LIG3 | CCNB2 994/4885CDK1 705/4885CCNB1 1125/4885 |
| US-12551519-B2 | Extraction system and method for organic metabolites | SHH, WNT1, WNT3A | CCNB2 732/4885CDK1 180/4885CCNB1 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.